At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,402 enrolled
Drug / intervention
Prizbind®drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Drug Use-results Survey (All-Case Surveillance) on Prizbind® for Intravenous Solution 2.5 g in Japan
In Brief
An observational study evaluating Prizbind® for Hemorrhage. Completed, enrolled 1,402 participants across 1 site.
Detailed Summary
To evaluate safety and effectiveness of Prizbind® for Intravenous Solution 2.5 g under Japanese clinical condition.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 2016
Enrollment StartNov 2016
Primary CompletionNov 2020
TodayJul 2026
First PostedOct 27, 2016
Enrollment StartNov 18, 2016
Primary CompletionNov 3, 2020
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 9.7 years ago
Interventions
Prizbind®drug
Prizbind®